MYGN stock pitch - 2018-01-30

Added to YB: 2018-01-30

Pitch date: 2018-01-30

Myriad Genetics, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests.

Market Cap

$625.5M

Pitch Price

$38.89

Price Target

N/A

Dividend

N/A

EV/EBITDA

-78.01

P/E

-1.54

EV/Sales

0.84

Sector

Biotechnology

A summary for this pitch has not been created yet.